INHIBITION OF NUCLEIC-ACID SYNTHESIS BY DI-N-BUTYL ESTER OF METHOTREXATE

被引:19
作者
CURT, GA [1 ]
TOBIAS, JS [1 ]
KRAMER, RA [1 ]
ROSOWSKY, A [1 ]
PARKER, LM [1 ]
TATTERSALL, MHN [1 ]
机构
[1] HARVARD UNIV,SCH MED,SIDNEY FARBER CANC CTR,DIV MED CHEM & PHARMACOL,BOSTON,MA 02215
关键词
D O I
10.1016/0006-2952(76)90047-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1943 / 1946
页数:4
相关论文
共 12 条
[1]  
EISENFELD A. J., 1962, PROC AMER ASSOC CANCER RES, V3, P316
[2]  
FISCHER GA, 1961, BIOCHEM PHARMACOL, V7, P75
[3]  
FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO
[4]  
2-J
[5]  
JOHNS DG, 1973, DRUG METAB DISPOS, V1, P580
[6]   ANTINEOPLASTIC ACTIVITY OF LIPID-SOLUBLE DIALKYL ESTERS OF METHOTREXATE [J].
JOHNS, DG ;
FARQUHAR, D ;
CHABNER, BA ;
WOLPERT, MK ;
ADAMSON, RH .
EXPERIENTIA, 1973, 29 (09) :1104-1105
[7]   INCREASED DIHYDROFOLATE REDUCTASE ACTIVITY AS A POSSIBLE BASIS OF DRUG RESISTANCE IN LEUKAEMIA [J].
MISRA, DK ;
GOLDIN, A ;
HUMPHREYS, SR ;
FRIEDKIN, M ;
CRAWFORD, EJ .
NATURE, 1961, 189 (475) :39-+
[8]   BIOCHEMICAL AND PHARMACOLOGIC STUDIES WITH 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-ADAMANTOATE (NSC-117614), A DEPOT FORM OF CYTARABINE [J].
NEIL, GL ;
BUSKIRK, HH ;
MOXLEY, TE ;
MANAK, RC ;
KUENTZEL, SL ;
BHUYAN, BK .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (12) :3295-&
[9]   METHODICHLOROPHEN AS ANTITUMOR DRUG [J].
PRICE, LA ;
GOLDIE, JH ;
HILL, BT .
BRITISH MEDICAL JOURNAL, 1975, 2 (5961) :20-21
[10]   METHOTREXATE ANALOGS .2. FACILE METHOD OF PREPARATION OF LIPOPHILIC DERIVATIVES OF METHOTREXATE AND 3',5'-DICHLOROMETHOTREXATE BY DIRECT ESTERIFICATION [J].
ROSOWSKY, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (10) :1190-1193